New Legislation Impacting Your Profession
HB 743 – Nonopioid Alternatives
Effective Date: July 1, 2020
HB 743 (Full Text)

Summary:

The bill revises these requirements for certain health care practitioners to inform patient or patient’s representative of nonopioid alternatives before prescribing or ordering an opioid drug by:

  • Requiring that the pamphlet provided to the patient be printed;
  • Authorizing a health care practitioner to discuss non-opioid alternatives with, and provide the pamphlet to, the patient’s representative rather than the patient;
  • Removing the requirement to address non-opioid alternatives when a drug is dispensed or administered; and
  • Exempting hospice services and care provided in a hospital critical care unit or emergency department from the requirement to discuss non-opioid alternatives with a patient.

Click here for more information and access the pamphlet.

An official website of the State of Florida How You Know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Latest News

New Legislation Impacting Your Profession

HB 743 – Nonopioid Alternatives
Effective Date: July 1, 2020
HB 743 (Full Text)

Summary:

The bill revises these requirements for certain health care practitioners to inform patient or patient’s representative of nonopioid alternatives before prescribing or ordering an opioid drug by:

  • Requiring that the pamphlet provided to the patient be printed;
  • Authorizing a health care practitioner to discuss non-opioid alternatives with, and provide the pamphlet to, the patient’s representative rather than the patient;
  • Removing the requirement to address non-opioid alternatives when a drug is dispensed or administered; and
  • Exempting hospice services and care provided in a hospital critical care unit or emergency department from the requirement to discuss non-opioid alternatives with a patient.

Click here for more information and access the pamphlet.